Vaccine 'Promising' for Delaying Relapse in KRAS-Mutated Pancreatic Cancer, CRC T-cell response linked to 86% reduced risk of relapse, death Jan 09, 2024
Homelessness Tied to Worse Cancer Outcomes Among Veterans However, all-cause mortality rates in lung, colon cancer lower versus other healthcare settings Dec 21, 2023
'Curable': A Case for Precision of Language Patients need a clear description of their prognosis Dec 19, 2023
GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients Association strongest in patients with overweight, obesity Dec 07, 2023
Diabetes Linked to Higher Colorectal Cancer Risk Associated risks highest in those with recent diagnoses Nov 14, 2023
Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparities A "local heroes effect" can better reach communities of color Nov 09, 2023
New Oral Drug Approved for Metastatic Colorectal Cancer In phase III trials of pretreated patients, fruquintinib improved survival versus placebo Nov 09, 2023
Personalized Intervention Helps CRC Screening Decisions for Older Adults Patients receiving intervention were less likely to undergo screening if benefits were low Oct 31, 2023
Chinese Compound for MI?; Knee Pain Management Also in TTHealthWatch: a new colorectal cancer screening test Oct 28, 2023 podcast
Novel Stool RNA Test More Sensitive for Detecting Colon Cancer Versus FIT ColoSense test outperforms fecal immunochemical testing in phase III trial Oct 25, 2023
Targeted Combination Wins in KRAS-Positive Metastatic Colorectal Cancer Standard dose of sotorasib plus panitumumab reduced risk of progression by 51% vs standard care Oct 23, 2023
Primary Care Intervention Improved Follow-Up of Abnormal Cancer Screening Results Follow-up testing within 120 days was improved with EHR reminders, patient outreach, navigation Oct 10, 2023
Cancer Risk in NAFLD Higher With Early Disease Onset 52% greater risk of malignancy for patients diagnosed with fatty liver disease before age 45 Sep 27, 2023
When Screening Guidelines Collide, Who Wins? A closer look at conflicting colorectal cancer screening recommendations Sep 26, 2023
Another Win for Biomarker-Driven Thromboprophylaxis for Patients With Cancer Threefold risk reduction with enoxaparin in high-risk gastrointestinal, lung cancers Sep 21, 2023
Could Cetuximab Maintenance Play a Role in RAS Wild-Type Metastatic CRC? Strategy tied to better outcomes but fails to meet primary goal of phase II trial Sep 18, 2023
Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
Study Links Being Breastfed to Cancer Risk in Adulthood But researchers say the established benefits likely outweigh any potential risk Sep 08, 2023
AI-Aided Colonoscopy Flops for Advanced Neoplasia Detection in Trial Meta-analysis turns up similar findings, though increased ADR overall Aug 28, 2023
Does Cancer Screening Actually Extend Lives? A series of articles look at whether the benefits for the few warrant the harms for the many Aug 28, 2023
Novel KRAS Inhibitor Leads to Durable Responses in Multiple Tumor Types More than half of patients with NSCLC, more than a third of those with CRC responded to divarasib Aug 23, 2023
ACP Sticks With Age 50 for Colorectal Cancer Screening Guidance conflicts with other new recommendations that screening start at age 45 Aug 01, 2023
Multi-Cancer Early Detection: 20th-Century Fiction Becomes Reality These tests could soon become a valuable addition to current cancer screening tools Aug 01, 2023
Age No Barrier to Preserved QoL, Functional Recovery After Surgery for CRC More than 70% of patients with a median age of 79 achieved both outcomes at 3-6 months Jul 13, 2023
Omitting RT Safe in Many Locally Advanced Rectal Cancers Most intermediate-risk cases can be cured without pelvic radiation, says investigator Jun 05, 2023
UnitedHealthcare in the Hot Seat Over GI Procedure 'Advance Notification' Policy New rule came in response to concerns over proposed prior authorization policy Jun 01, 2023
Medicaid Expansion Tied to Better Outcomes in Black Patients With GI Cancers Two-year mortality decreased for three types of GI cancer in expansion vs non-expansion states May 25, 2023
Warning: Prior Auth for Colonoscopy Is the Wrong Way to Go The policy adds delays to care and may worsen health outcomes May 24, 2023
Anti-EGFR Rechallenge Boosts PFS in Third-Line Metastatic Colorectal Cancer ctDNA-identified wild-type tumors benefited most from adding panitumumab to standard therapy May 23, 2023
AI in Colonoscopy: Disconnect Grows Between Academic, Community Studies Clearly helpful in manufacturers' trials, but not so much in routine practice May 09, 2023
Study: VA Surgeons Who Do Colonoscopies May Need More Training Outdone by gastroenterologists in finding adenomatous polyps May 08, 2023
Medicaid Expansion Seen Lifting Colon Cancer Screening for Low-Income People But not a cure-all in states boosting eligibility May 06, 2023
HIPEC With Mitomycin C Reduces Locoregional Recurrence in High-Risk Colon Cancer No increase in adverse events or toxicity versus surgery alone Apr 26, 2023
Genomics Add Insight Into Worse Colorectal Cancer Outcomes in Black Patients Fewer actionable mutations, less likely to meet genomic criteria for immunotherapy Apr 19, 2023
Many With Cancer Predisposition Diseases Unaware of Genetic Status Moreover, a significant proportion do not qualify for genetic screening under current guidelines Apr 19, 2023
Does Your 80-Year-Old Patient Really Need That Colonoscopy? Physicians often ignore life expectancy in screening decisions, study finds Apr 04, 2023
Take Risk Into Account Before Repeat Surveillance Colonoscopy, Study Says 58% of seniors with limited life expectancy, no significant findings invited for another round Mar 14, 2023
KRAS Mutations in Metastatic CRC Predict Survival Benefit of Chemo Combo Trifluridine/tipiracil fails to improve survival in patients with KRAS G12-mutant tumors Mar 06, 2023
'Alarming' Rise in Colon Cancer Rates Among Younger People Rate doubled in under-50 age group since 1995, concerning trend toward more advanced disease Mar 01, 2023
FDA Has Concerns on 'Unprecedented' Plan for Dostarlimab in Rectal Cancer Panel will discuss if single-arm trials and proposed endpoints are adequate to support approval Feb 08, 2023
